This review demonstrates the transformative impact of AR and VR technologies in healthcare, highlighting regulatory challenges.
Augmented Reality (AR) and Virtual Reality (VR) technologies are revolutionizing healthcare by offering transformative solutions across various medical disciplines. AR enhances surgical precision through real-time imaging overlays, enabling surgeons to visualize critical structures during procedures and improve outcomes. It also improves medical training by offering immersive simulations that enable healthcare professionals to rehearse complex procedures in a safe, risk-free setting. It also enhances medical training by providing immersive simulations that allow healthcare professionals to practice complex procedures in a risk-free environment. Furthermore, AR empowers patient education with interactive models, enabling clearer explanations of medical conditions and treatment options, thereby enhancing patient understanding and engagement in their care. On the other hand, VR facilitates therapeutic interventions by creating immersive environments that aid in pain management, rehabilitation, and mental health treatments. Patients undergoing physical therapy or rehabilitation can benefit from VR simulations that provide interactive exercises and motivational scenarios, accelerating recovery and improving outcomes. Moreover, VR is increasingly utilized in mental health settings to treat anxiety disorders and phobias by immersing patients in controlled virtual environments, allowing them to face and manage their conditions effectively. The regulatory landscape for AR/VR medical devices is overseen by bodies such as the Food and Drug Administration, European Medicines Agency, and other global regulators, ensuring the safety and efficacy of these technologies through rigorous testing and adherence to quality standards. Collaboration between innovators, healthcare providers, and regulators is crucial to navigating these frameworks effectively and leveraging the full potential of AR and VR in healthcare. This paper will explore the transformative impact and regulatory considerations of AR and VR medical devices in healthcare.
No takes yet. Share an insight, caveat, or question.
Kaur et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: